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We describe the synthesis of 12 new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives on solid supports with 
room temperature and microwave-assisted solvent-free procedures. Results show that solid supports have good catalytic activity in 
the formation of quinoxaline 1,4-di-N-oxide derivatives. We found that florisil and montmorillonite KSF and K10 could be used as 
new, easily available, inexpensive alternatives of catalysts. Additionally, room temperature and microwave-irradiation solvent-free 
synthesis was more efficient than a conventional procedure (Beirut reaction), reducing reaction time and increasing yield.
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INTRODUCTION
Quinoxaline has numerous biological properties and has been 
studied as an anti-leishmanial, anti-fungal, anti-bacterial, anti-Chagas, 
and anti-tumoral agent.1-4 Quinoxaline 1,4-di-N-oxide is a versatile 
scaffold with diverse activities (Figure 1).5-8
A conventional procedure known as the Beirut reaction has been 
used for the synthesis of quinoxaline 1,4-di-N-oxide by various au-
thors. The reaction mechanism involves the presence of triethylamine 
as a base capable of removing a proton from α-methylene transferring 
it to the carbonyl group of the 2,4-diketone, forming a carbanion, 
which performs a nucleophilic attack on the positive nitrogen of 
benzofuroxane. Subsequently, there is a nucleophilic attack of a 
second nitrogen on the carbonyl group with the resulting cycliza-
tion and reorganization binding (Figure 2); however, this procedure 
has several limitations such as a low yield and a prolonged reaction 
time.9-12 Therefore, the development of new catalysts for the synthesis 
of quinoxaline 1,4-di-N-oxide derivatives is highly desirable.
The use of solid supports in various chemical syntheses has 
recently been documented.13-15 Additionally, some solid supports 
with catalytic activity, such as montmorillonite KSF and K10,  have 
been widely studied as reusable catalysts.16-18 Several methods have 
Figure 1. Structure of some active quinoxaline 1,4-di-N-oxide derivatives
Figure 2. Synthesis and reaction mechanism of quinoxaline 1,4-di-N-oxide 
by the Beirut reaction
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been reported for the synthesis of quinoxaline derivatives using solid 
supports and microwave-assisted reactions.19-24
The aim of this study was the synthesis of new ethyl and me-
thyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives on solid 
supports such as silica gel, florisil, alumina, 4Å molecular sieves, 
montmorillonite KSF, and montmorillonite K10, by room tempera-
ture and microwave-assisted solvent-free procedures (Figure 3), as 
a strategy to enhance yield and reduce the reaction time as a part of 
our ongoing research in the design and synthesis of new compounds 
with potential pharmacological activity.
RESULTS AND DISCUSSION
As a part of our ongoing research in the synthesis of new anti-
Chagas, anti-tumoral, and anti-mycobacterial agents, we developed 
12 new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide 
derivatives using a previously reported conventional procedure (the 
Beirut reaction)11, 12 shown in Table 1. Unfortunately, we obtained 
ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide deri-
vatives with a low yield (0.4-23.2%). Some authors have used the 
Beirut reaction to synthesize various heterocyclic compounds by 
reacting benzofuroxane with enolates and enamines reporting good to 
excellent yields; however, when β-keto esters and diketones in basic 
medium (triethylamine) are used, low yields of quinoxaline 1,4-di-N-
oxide derivatives are obtained.9,10 Considering the generation of the 
carbanion on α-methylene as a key step in the reaction mechanism 
that forms quinoxaline, we propose that there was greater difficulty 
in generating the carbanion on β-keto ester derivatives by effect re-
sonance, which may explain the low yields in entry 4 and 5 and the 
lack of compounds in 3 and 10. This behavior could also explain the 
low yield in aromatic diketones, but this conclusion is not definite 
and needs further experimentation.
As an alternative strategy in the synthesis of quinoxaline 
1,4-di-N-oxide derivatives, we proposed the use of solid supports 
such as silica gel, alumina and 4Å molecular sieves that have 
been reported to have catalytic activity and enhance yield in the 
synthesis of quinoxaline 1,4-di-N-oxide.25 We included florisil, 
montmorillonite KSF and K10 as new solid supports with poten-
tial catalytic activity. The reaction system starting with methyl 
benzofuroxane-5-carboxylate and 1-benzoylacetone (entry 1) 
without the addition of solid supports and monitored with thin 
layer chromatography at different times for 48 h, did not proceed, 
but when solid supports from a room temperature solvent-free 
procedure were used, we obtained compounds like those synthe-
sized by the conventional procedure with an enhanced yield and 
a shorter reaction time (Table 2).
Figure 3. General procedure for the synthesis of new ethyl and methyl 
quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives on solid supports by 
room temperature and microwave-assisted solvent-free procedures
Table 1. Ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide deriva-
tives obtained by conventional procedure (Beirut reaction)
Entry R2 R3 R7 Yield %
1 C6H5 CH3 CH3OOC 10
2 NHC6H5 CH3 CH3OOC 5.04
3 OCH3 CH3 CH3OOC 0
4 OCH3CH2 CH3 CH3OOC 1.50
5 OC(CH3)3 CH3 CH3OOC 0.4 
6 C6H5 CF3 CH3OOC 10.9 
7 C4H3S CF3 CH3OOC 5.6 
8 C6H5 CH3 CH3CH2OOC 12.3 
9 NHC6H5 CH3 CH3CH2OOC 22.4
10 OCH3 CH3 CH3CH2OOC 0 
11 C6H5 CF3 CH3CH2OOC 2.3
12 C4H3S CF3 CH3CH2OOC 23.2 
Table 2. Ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives obtained by room temperature and microwave-assisted solvent-free procedures
Entry
Room temperature (%) Microwave-assisted (%)
F A S MS KSF K10 F A S MS KSF K10
1 70* 40* 25* 20≈ 25* 25≈ 60 a 50 a 70 c 50 b 65 b 55 b
2 40* 20≈ 20≈ 0* 20≈ 25≈ 60 a 50 b 40 b 20 c 50 b 30 a
3 60* 30≈ 0* 0* 0* 0* 40 a 60 c 0 c 20 c 0 c 0 c
4 40≈ 15* 0* 80≈ 0* 0* 80 a 70 c 0 c 80 c 35 b 10 c
5 20* 20* 0* 0* 0* 30* 40 b 50 a 40 b 25 b 20 b 0 c
6 30* 20≈ 20* 5≈ 0* 5≈ 30 a 30 b 35 a 20 a 15 c 20 a
7 20≈ 20≈ 40* 20≈ 20≈ 20≈ 20 c 30 a 40 c 25 a 35 c 55 b
8 40≈ 40≈ 35≈ 10* 70≈ 90≈ 60 a 60 a 50 c 0 c 30 b 20 b
9 60≈ 30≈ 40≈ 40≈ 30≈ 50≈ 60 a 50 a 30 a 15 a 30 b 35 a
10 50≈ 30* 20≈ 30≈ 30≈ 40≈ 30 a 20 a 40 a 15 a 25 40 a
11 40≈ 60≈ 60≈ 60≈ 50≈ 60≈ 70 b 60 a 80 a 50 a 700 70 a
12 50≈ 60≈ 20≈ 5≈ 40≈ 20≈ 70 c 70 a 40 a 0 c 70 b 35 c
F = Florisil, A = Alumina, S = Silica gel, MS = 4Å Molecular sieves, KSF = Montmorillonite KSF, K10 = Montmorillonite K10. Time: ≈1 h, * ≥ 24 h, a 5 min, 
b
 10 min, c 15 min and d 45 min
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Analyzing the data of entry 1 using a room temperature solvent-
free procedure, we found that there was a sevenfold and fourfold 
increase in yield with florisil (70%) and alumina (40%) as solid 
supports, respectively. This contrasted with the yield obtained by 
conventional procedure (10%). When silica gel, 4 Å molecular sieves, 
montmorillonite KSF and K10 were used, we obtained only a twofold 
yield (20%). Although the results did not show a consistent pattern of 
enhanced yield with the other 2,4-diketone derivatives, this procedure 
was more efficient and effective than the conventional procedure, with 
florisil and alumina solid supports having the best catalytic activity. 
The yield increase obtained with solid supports may be due to the 
incorporation of 2,4-diketone derivatives on the surface of the solid 
supports, which allow better nucleophilic attack by the nitrogen of 
benzofuroxane as shown in Figure 4.26 We propose that the nature 
of each solid support promotes the incorporation of 2,4-diketone 
derivatives more efficiently on the surface.
We unexpectedly found that in the reaction in entry 3, 4, and 5 
using β-keto esters, the desired product was not obtained with silica 
gel, montmorillonite KSF or K10. This may be due to a greater 
interaction of the β-keto ester derivatives on solid supports, which 
prevents the formation of the quinoxaline derivative.27,28 This behavior 
may also explain the low yield obtained with florisil and alumina.
In a third strategy to obtain quinoxaline 1,4-di-N-oxide derivatives 
more efficiently, we carried out a microwave-assisted procedure using 
the same solid supports under solvent-free conditions (Table 2). In this 
procedure we obtained ethyl and methyl quinoxaline-7-carboxylate 
1,4-di-N-oxide derivatives with a more efficient reaction time, 5 to 
45 min versus 1 h and days with room temperature solvent-free and 
the conventional procedure, respectively. This short reaction time 
may be caused by the heating effect of microwaves. Although this 
heating effect is important, it should be considered that it can also 
cause the formation of undesired subproducts such as quinoxaline 
reduction derivatives. The catalytic activity in the condensation of 
benzofuroxane and β-keto esters and 2,4-diketone derivatives using 
the microwave-assisted procedure was more efficient, with florisil 
and alumina showing the best yields. Other solid supports also sho-
wed good yields, but our results with silica gel were different from 
those reported by Yusuke et al.. This was because they synthesized 
quinoxaline 1,4-di-N-oxide derivatives on silica gel in solvent-free 
conditions under microwave irradiation in only two minutes while 
we showed results in five minutes or more.29 
Finally, our results show that florisil is a new solid support with 
catalytic activity and that montmorillonite KSF and K10 are additio-
nal alternatives for obtaining quinoxaline 1,4-di-N-oxide derivatives 
from benzofuroxane and β-ketoesters and 2,4-diketone derivatives. 
CONCLUSION
In summary, our results show that solid supports have good 
catalytic activity in the formation of ethyl and methyl quinoxaline-
7-carboxylate 1,4-di-N-oxide derivatives. We found that florisil and 
montmorillonite KSF and K10 can be used as new, efficient, easily 
available, and inexpensive alternative catalysts. Additionally, the 
synthesis of quinoxaline 1,4-di-N-oxide derivatives using room tem-
perature and microwave-assisted solvent-free procedures is simpler, 
quick, and more efficient than a conventional procedure, reducing 
reaction time and increasing yield.
EXPERIMENTAL 
General procedure for the synthesis of quinoxaline 1,4-di-N-
oxide derivatives
Conventional procedure (Beirut reaction) 
We added 30 mL of dry chloroform, benzofuroxane derivative 
(5 mmol) and 2,4-diketone derivative (10 mmol) at 0 ºC to 50 mL 
round-bottomed flasks, and a catalytic amount of triethylamine and 
stirred the mixture at room temperature for 4-7 days. Progress of the 
reaction was monitored by thin layer chromatography. Afterwards, 
the obtained compound was purified by column chromatography 
using dichloromethane:methanol (95:5).
Room temperature solvent-free procedure
We added 20 mL of dry chloroform, benzofuroxane derivative 
(5 mmol), 2,4-diketone derivative (10 mmol), and 500 mg of solid 
support at room temperature to a 50 mL round-bottomed flask. 
After the reagents had dissolved, the solvent was then evaporated 
under reduced pressure and dried in a vacuum pump. Progress of 
the reaction was monitored by thin layer chromatography from 5 
min to 24 h. After completion of the reaction, we added dichlo-
romethane, and the solid support was removed by filtration. The 
crude compound was purified by column chromatography using 
dichloromethane:methanol (95:5).
Solvent-free using microwave-assisted procedure
We added 20 mL of dry chloroform, benzofuroxane derivative 
(5 mmol), 2,4-diketone derivative (10 mmol) and 500 mg of solid 
support at room temperature to a 50 mL round-bottomed flask. 
After the reagents had dissolved, the solvent was then evaporated 
under reduced pressure and the mixture exposed to a CEM mi-
crowave (temperature = 60 ºC, power = 300 W) for 3 periods of 5 
min or more. After completion of the reaction, we added dichlo-
romethane, and the solid support was removed by filtration. The 
crude compound was purified by column chromatography using 
dichloromethane:methanol (95:5).
All products were characterized by infrared (IR) and nuclear 
magnetic resonance (NMR) spectra. NMR was recorded on a Bruker 
Ultrashield 400 MHz device, using Tetramethylsilane (TMS) as 
the internal standard and Dimethylsulfoside-d6 (DMSO-d6) as a 
solvent. The chemical shifts are reported in ppm (d), and coupling 
constant (J) values are given in hertz (Hz). Signal multiplicities are 
represented by s (singlet), d (doublet), t (triplet), c (quadruplet) and 
Figure 4. Reaction mechanism of quinoxaline 1,4-di-N-oxide on solid supports 
at room temperature
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m (multiplet). The infrared (IR) spectra were performed on a Perkin 
Elmer 1600 FTIR in KBr Pellets. The frequencies are expressed in 
cm-1. Alugram1 SIL G/UV254 (Layer: 0.2 mm) was used for thin 
layer chromatography.
Entry 1: Methyl 2-benzoyl-3-methylquinoxaline-7-carboxylate 1,4-di-
N-oxide. IR (KBr) u/cm-1: 1726 and 1674 (C=O), 1328 (N-oxide); 
1H-NMR (DMSO-d6) d/ppm: 2.32 (s, 3H, CH3), 3.99 (s, 3H, CH3O), 
7.59 (t, J= 7.67 Hz, 2H, H3 and H5, C6H5), 7.78 (t, J= 7.33 Hz, 1H, 
H4, C6H5), 8.08 (d, J= 7.51 Hz, 2H, H2 and H6, C6H5), 8.37 (d, J= 
1.17 Hz, 1H, H6,), 8.49 (d, 1H, H5), 8.96 (m, 1H, H8). 
Entry 2: Methyl 2-phenylcarbamoyl-3-methylquinoxaline-7-carbo-
xylate 1,4-di-N-oxide. IR (KBr) u/cm-1: 1728 and 1684 (C=O), 1336 
(N-oxide); 1H NMR (DMSO-d6) d/ppm: 2.52 (s, 3H, CH3), 3.99(s, 
3H, CH3O), 7.2 (t, J= 7.38 Hz, 1H, NHC6H5), 7.42 (t, J= 7.78 Hz, 2H, 
H3 and H5, NHC6H5), 7.67 (d, J= 7.92 Hz, 2H, H2 and H6, NHC6H5), 
8.41 (d, J= 8.84 Hz, 1H, H6), 8.62 (d, J= 8.93 Hz, 1H, H5), 9.0 (s, 
1H, H8), 11.01 (s, 1H, NH).
Entry 3: Dimethyl 3-methylquinoxaline-2,7-di-carboxylate 1,4-di-
N-oxide. IR (KBr) u/cm-1:  2957 (ArC-H), 1716 (C=O), 1320 (N-
oxide); 1H NMR (DMSO-d6) d/ppm: 2.44 (s, 3H, CH3), 3.96 (s, 3H, 
CH3OCO), 4.04 (s, 3H, COOCH3), 8.39 (d, J= 8.9 Hz, 1H, H6), 8.56 
(d, J= 8.9 Hz, 1H, H5), 8.85 (s, 1H, H8).
Entry 4: Ethyl methyl-3-methylquinoxaline-2,7-di-carboxylate 1,4-di-
N-oxide. IR (KBr)  u/cm-1: 1740 and 1719 (C=O), 1326 (N-oxide); 
1H NMR (DMSO-d6) d/ppm: 1.32(t, 3H, CH3CH2O) 2.45 (s, 3H, 
CH3), 3.97 (s, 3H, CH3O), 4.52 (c, 2H, CH3CH2O), 8.39 (d, J= 1.80 
and 8.97 Hz, 1H, H6), 8.56 (d, J= 1.72 Hz, 1H, H5), 8.86 (m, 1H, H8).
Entry 5: Tertbutyl methyl-3-methylquinoxaline-2,7-di-carboxylate 
1,4-di-N-oxide. IR (KBr)  u/cm-1: 2976 (ArC-H), 1732 and 1718 
(C=O), 1330 (N-oxide);1H NMR (DMSO-d6) d/ppm: 1.32 (s, 9H, 
(O(CH3)3),  2.45 (s, 3H, CH3), 3.96 (s, 3H, CH3O), 8.36 (t, J= 9.4 Hz, 
1H, H6), 8.58 (m, 1H, H5), 8.88 (m, J= 13.2 Hz, 1H, H8).
Entry 6: Methyl 2-benzoyl-3-methylquinoxaline-7-carboxylate 1,4-di-
N-oxide. IR (KBr) u/cm-1: 2949 (ArC-H), 1726 and 1674 (C=O), 1328 
(N-oxide);1H NMR (DMSO-d6) d/ppm: 2.54 (t, 3H, CH3); 4.04 (s, 
3H, CH3O), 7.57 (t, J = 8.1 Hz, 2H, H3 and H5, C6H5), 7.72 (s, 1H, 
H4, C6H5), 7.91 (d, J= 1.4 Hz, 2H, H2 y H6, C6H5), 8.52 (d, J= 9.0 Hz, 
1H, H6), 8.76 (s, 1H, H5), 9.23 (s, 1H, H8).
Entry 7: Methyl 2-(2-thienylcarbonyl)-3-trifluoromethylquinoxaline-
7-carboxylate 1,4-di-N-oxide. IR (KBr) u/cm-1: 1732 and 1664 (C=O), 
1360 (N-oxide); 1H NMR (DMSO-d6) d/ppm: 3.78 (s, 3H, CH3O), 
7.32 (s, 1H, C4H3S), 8.28 (d, J= 2.57 Hz, 2H, C4H3S), 8.5 (d, 2H, H5 
and H6), 8.96 (s, 1H, H8).
Entry 8: Ethyl 2-benzoyl-3-methylquinoxaline-7-carboxylate 1,4-di-
N-oxide. IR (KBr) u/cm-1: 1720 and 1684 (C=O), 1331 (N-oxide); 1H 
NMR  (DMSO-d6) d/ppm: 1.4 (t, J= 7.11 Hz, 3H, CH3CH2O), 2.32 
(s, 3H, CH3), 4.5 (c, J= 7.10 Hz, 2H, CH3CH2O), 7.6 (t, J= 7.79 Hz, 
2H, H3 and H5, C6H5), 7.8 (t, J= 7.43 Hz, 1H, H4, C6H5), 8.1 (d, J= 
7.35 Hz, 2H, H2 and H6, C6H5), 8.4 (d, J= 1.72 Hz, 1H, H6), 8.5 (s, 
1H, H5), 8.92 (m, 1H, H8).
Entry 9: Ethyl 2-phenylcarbamoyl-3-methylquinoxaline-7-carboxyla-
te 1,4-di-N-oxide. IR (KBr) u/cm-1: 2982 (ArC-H), 1726 and 1684 
(C=O), 1333 (N-oxide); 1H NMR: 1.36-1.40 (m, 6H, CH3CH2O and 
CH3); 4.40-4.46 (m, 2H, CH3CH2O), 7.2 (t, J= 7.34 Hz, 1H, NHC6H5), 
7.39-7.44 (m, 2H, H3 and H5, NHC6H5), 7.64-7.66 (m, 2H, H2 and 
H6, NHC6H5), 8.38-8.42 (m, 1H, H6), 8.58-8.61 (m, 1H, H5), 8.96 (s, 
1H, H8), 11.10 (s, 1H, NH).
Entry 10: Methyl ethyl -3-methylquinoxaline-2,7-di-carboxylate 
1,4-di-N-oxide. IR (KBr)  u/cm-1:  2982 (ArC-H), 1715 (C=O), 1333 
(N-oxide); 1H NMR (DMSO-d6) d/ppm: 1.38 (s, 3H, CH3CH2O), 2.64 
(s, 3H, CH3), 3.99 (s, 3H, COOCH3), 4.41 (s, 2H, CH3CH2O), 8.27 
(m, 1H, H6), 8.54 (s, 1H, H5), 8.91 (s, 1H, H8).
Entry 11: Ethyl 2-benzoyl-3-trifluoromethylquinoxaline-7-carboxyla-
te 1,4-di-N-oxide. IR (KBr) u/cm-1: 2987 (ArC-H), 1735 (C=O), 1357 
(N-oxide), 1261 and 1158 (Ar-CF3); 1H NMR  (DMSO-d6) d/ppm: 1.4 
(t, J= 7.11 Hz, 3H, CH3CH2O); 4.5 (c, J= 7.08 Hz, 2H, CH3CH2O), 
7.6 (m, 2H, H3 and H5, C6H5), 7.8 (m, 1H, H4, C6H5), 8.2 (m, 2H, H2 
and H6, C6H5), 8.5 (m, 2H, H5 and H6), 9.0 (m, 1H, H8).
Entry 12: Ethyl 2-(2-thienylcarbonyl)-3-trifluoromethylquinoxaline-
7-carboxylate 1,4-di-N-oxide. IR (KBr) u/cm-1: 1726 and 1665 (C=O), 
1336 (N-oxide), 1H NMR (DMSO-d6) d/ppm: 1.4 (t, J= 7.11 Hz, 3H, 
CH3CH2O); 4.5 (c, J= 7.07 Hz, 2H, CH3CH2O), 7.30-7.33 (m, 1H, H4, 
C4H3S), 8.2 (dd, J= 3.83 and 0.76 Hz, H5, C4H3S), 8.3 (dd, J= 4.83 and 
0.74 Hz, H3, C4H3S), 8.50-8.57 (m, 2H, H5 and H6), 8.96 (m, 1H, H8).
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